American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention

Heart Rhythm

Volumn 5, Issue 10, 2008, Pages

  Goldberger, Jeffrey J ^a   Cain, Michael E ^a   Hohnloser, Stefan H ^a   Kadish, Alan H ^a   Knight, Bradley P ^a   Lauer, Michael S ^a   Maron, Barry J ^a   Page, Richard L ^a   Passman, Rod S ^a   Siscovick, David ^a   Stevenson, William G ^a   Zipes, Douglas P ^a  

^a NONE

Author keywords

AHA Scientific Statements; death, sudden; risk assessment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPLERENONE; FIBRINOLYTIC AGENT; METOPROLOL; PROCAINAMIDE;

ACUTE HEART INFARCTION; ARRHYTHMOGENESIS; ARTICLE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EXERCISE TEST; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; MEDICAL SOCIETY; MORTALITY; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PREDICTION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; QT DISPERSION; QT INTERVAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN DEATH; T WAVE;

AMERICAN HEART ASSOCIATION; DEATH, SUDDEN, CARDIAC; HUMANS; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 53049108992     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.05.031     Document Type: Article

References (206)

1. Pratt C.M., Greenway P.S., Schoenfeld M.H., et al. Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation 93 (1996) 519-524
2. Goldberger J.J., Weinberg K.M., and Kadish A.H. Impact of nontraditional antiarrhythmic drugs on sudden cardiac death. In: Zipes D., and Jalife J. (Eds). Cardiac Electrophysiology: From Cell to Bedside. 4th ed. (2004), WB Saunders, Philadelphia, Pa 950-958
3. Myerburg R.J., Mitrani R., Interian Jr. A., et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 97 (1998) 1514-1521
4. Heller R.F., Chinn S., Pedoe H.D., et al. How well can we predict coronary heart disease?. Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed) 288 (1984) 1409-1411
5. Rose G.A. The Strategy of Preventive Medicine (1992), Oxford University Press, Oxford, UK
6. Wackers F.J., Berger H.J., Johnstone D.E., et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol 43 (1979) 1159-1166
7. McGowan J.H., and Cleland J.G. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 146 (2003) 388-397
8. Bigger Jr. J.T., Fleiss J.L., Kleiger R., et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69 (1984) 250-258
9. Sanz G., Castañer A., Betriu A., et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 306 (1982) 1065-1070
10. Risk stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
11. Volpi A., De Vita C., Franzosi M.G., et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base: the Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 88 (1993) 416-429
12. Huikuri H.V., Tapanainen J.M., Lindgren K., et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 42 (2003) 628-652
13. McClements B.M., and Adgey A.A. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute infarction in the thrombolytic era. J Am Coll Cardiol 21 (1993) 1419-1427
14. Bailey J.J., Berson A.S., Handelsman H., et al. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 38 (2001) 1902-1911
15. Hohnloser S.H., Kuck K.H., Dorian P., et al., DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
16. Solomon S.D., Zelenkofske S., McMurray J.J., et al., Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
17. Bigger Jr. J.T., and Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
18. Moss A.J., Hall W.J., Cannom D.S., et al., Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
19. Moss A.J., Fadl Y., Zareba W., et al., Defibrillator Implantation Trial Research Group. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol 88 (2001) 516-520
20. Buxton A.E., Lee K.L., Hafley G.E., et al., MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial. Circulation 106 (2002) 2466-2472
21. Moss A.J., Zareba W., Hall W.J., et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
22. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
23. Dec G.W., and Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 331 (1994) 1564-1575
24. Grimm W., Christ M., Bach J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study. Circulation 108 (2003) 2883-2891
25. Kadish A., Dyer A., Daubert J.P., et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
26. Shamim W., Yousufuddin M., Cicoria M., et al. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 88 (2002) 47-51
27. Desai A.D., Yaw T.S., Yamazaki T., et al. Prognostic significance of quantitative QRS duration. Am J Med 119 (2006) 600-606
28. Nichol G., Kaul P., Huszti E., et al. Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med 141 (2004) 343-351
29. Shamim W., Francis D.P., Yousufuddin M., et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 70 (1999) 171-178
30. Park R.C., Little W.C., and O'Rourke R.A. Effect of alteration of left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. Circ Res 57 (1985) 706-717
31. Vassallo J.A., Cassidy D.M., Miller J.M., et al. Left ventricular endocardial activation during right ventricular pacing: effect of underlying heart disease. J Am Coll Cardiol 7 (1986) 1228-1233
32. Akar F.G., Spragg D.D., Tunin R.S., et al. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 95 (2004) 717-725
33. Freedman R.A., Alderman E.L., Sheffield L.T., et al. Bundle branch block in patients with chronic coronary artery disease: angiographic correlates and prognostic significance. J Am Coll Cardiol 10 (1987) 73-80
34. McCullough P.A., Philbin E.F., Spertus J.A., et al., Resource Utilization Among Congestive Heart Failure (REACH) Study. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39 (2002) 60-69
35. Baldasseroni S., Opasich C., Gorini M., et al., Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 143 (2002) 398-405
36. Iuliano S., Fisher S.G., Karasik P.E., et al., Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure. Am Heart J 143 (2002) 1085-1091
37. Greenberg H., Case R.B., Moss A.J., et al., MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43 (2004) 1459-1465
38. Centers for Medicare & Medicaid Services. National coverage determination on implantable defibrillators. http://www.cms.hhs.gov/coverage/download/id39-5.pdf
39. Zimetbaum P.J., Buxton A.E., Batsford W., et al. Electrocardiographic predictors of arrhythmic death and total mortality in the Multicenter Unsustained Tachycardia Trial. Circulation 110 (2004) 766-769
40. Buxton A.E., Sweeney M.O., Wathen M.S., et al., PainFREE Rx II Investigators. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol 46 (2005) 310-316
41. Singh J.P., Hall W.J., McNitt S., et al., MADIT-II Investigators. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 46 (2005) 1712-1720
42. Hofmann T., Meinertz T., Kasper W., et al. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 116 (1988) 1455-1463
43. Romeo F., Pelliccia F., Cianfrocca C., et al. Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 63 (1989) 138-140
44. Vaidean G.D., Schroeder E.B., Whitsel E.A., et al. Short-term repeatability of electrocardiographic spatial T-wave axis and QT interval. J Electrocardiol 38 (2005) 139-147
45. Padmanabhan S., Silvet H., Amin J., et al. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results from a cohort of 2265 patients with an ejection fraction of < or =40%. Am Heart J 145 (2003) 132-138
46. Gang Y., Ono T., Hnatkova K., et al., ELITE II Investigators. QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy. Pacing Clin Electrophysiol 26 (2003) 394-400
47. Brendorp B., Elming H., Jun L., et al., Diamond Study Group. QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 103 (2001) 1422-1427
48. Elming H., Holm E., Jun L., et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19 (1998) 1391-1400
49. Dekker J.M., Crow R.S., Hannan P.J., et al., ARIC Study. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and while middle-aged men and women: the ARIC study. J Am Coll Cardiol 43 (2004) 565-571
50. Davey P. QT interval and mortality from coronary artery disease. Prog Cardiovasc Dis 42 (2000) 359-384
51. Pinsky D.J., Sciacca R.R., and Steinberg J.S. QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 29 (1997) 1576-1584
52. Malik M., and Batchvarov V.N. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 36 (2000) 1749-1766
53. Sakabe K., Ikeda T., Sakata T., et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Jpn Heart J 42 (2001) 451-457
54. Brendorp B., Elming H., Jun L., et al., DIAMOND Study Group. Danish Investigations Of Arrhythmia and Mortality On Dofetilide. Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure. Eur J Heart Fail 4 (2002) 201-206
55. Brendorp B., Elming H., Jun L., et al. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 103 (2001) 831-835
56. Chevalier P., Burri H., Adeleine P., et al., Groupe d'Etude du Pronostic de l'Infarctus du Myocarde. QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol 14 (2003) 227-233
57. Hintze U., Vach W., Burchardt H., et al., DIAMOND Study Group. QT interval dynamics predict mortality in high-risk patients after myocardial infarction. Scand Cardiovasc J 36 (2002) 276-281
58. Bonnemeier H., Hartmann F., Wiegand U.K., et al. Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. J Am Coll Cardiol 37 (2001) 44-50
59. Haigney M.C., Zareba W., Gentlesk P.J., et al., Multicenter Automatic Defibrillator Implantation Trial II investigators. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 44 (2004) 1481-1487
60. Berger R.D., Kasper E.K., Baughman K.L., et al. Beat-to-beat QT interval variability: novel evidence for repolarization in lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 96 (1997) 1557-1565
61. Batchvarov V.N., Ghuran A., Smetana P., et al. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol 282 (2002) H2356-H2363
62. Gardner P.I., Ursell P.C., Fenoglio Jr. J.J., et al. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 72 (1985) 596-611
63. Simson M.B., Untereker W.J., Spielman S.R., et al. Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia. Am J Cardiol 51 (1983) 105-112
64. el-Sherif N., Gough W.B., Restivo M., et al. Electrophysiological basis of ventricular late potentials. Pacing Clin Electrophysiol 13 (1990) 2140-2147
65. Wiener I., Mindich B., and Pitchon R. Fragmented endocardial electrical activity in patients with ventricular tachycardia: a new guide to surgical therapy. Am Heart J 107 (1984) 86-90
66. Cassidy D.M., Vassallo J.A., Buxton A.E., et al. The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia. Circulation 69 (1984) 1103-1110
67. Manolis A.S., Chiladakis J.A., Malakos J.S., et al. Abnormal signal-averaged electrocardiograms in patients with incomplete right bundle-branch block. Clin Cardiol 20 (1997) 17-22
68. Okin P.M., Stein K.M., Lippman N., et al. Performance of the signal-averaged electrocardiogram: relation to baseline QRS duration. Am Heart J 129 (1995) 932-940
69. Gatzoulis K.A., Carlson M.D., Biblo L.A., et al. Time domain analysis of the signal averaged electrocardiogram in patients with a conduction defect or a bundle branch block. Eur Heart J 16 (1995) 1912-1919
70. Savard P., Rouleau J.L., Ferguson J., et al. Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation 96 (1997) 202-213
71. Kirchhof P., Eckardt L., Arslan O., et al. Prolonged QRS duration increases QT dispersion but does not relate to arrhythmias in survivors of acute myocardial infarction. Pacing Clin Electrophysiol 24 (2001) 789-795
72. Reinhardt L., Mäkijärvi M., Fetsch T., et al. Noninvasive risk modeling after myocardial infarction. Am J Cardiol 78 (1996) 627-632
73. Marques-Vidal P., Ruidavets J.B., Prouteau N., et al. Prevalence of late potentials in a sample of 487 healthy, middle-aged men from southwestern France. Pacing Clin Electrophysiol 23 (2000) 888-890
74. el-Sherif N., Denes P., Katz R., et al., The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 25 (1995) 908-914
75. Engel T.R., Pierce D.L., and Murphy S.P. Variation in late potentials and the reproducibility of their measurement. Prog Cardiovasc Dis 35 (1993) 247-262
76. Goldberger J.J., Challapalli S., Waligora M., et al. Uncertainty principle of signal-averaged electrocardiography. Circulation 101 (2000) 2909-2915
77. Pogwizd S.M., Hoyt R.H., Saffitz J.E., et al. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 86 (1992) 1872-1887
78. Hood M.A., Pogwizd S.M., Peirick J., et al. Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs. Circulation 86 (1992) 1888-1901
79. Reinhardt L., Mäkijärvi M., Fetsch T., et al. Predictive value of wavelet correlation functions of signal-averaged electrocardiogram in patients after anterior versus inferior myocardial infarction. J Am Coll Cardiol 27 (1996) 53-59
80. Vázquez R., Caref E.B., Torres F., et al. Reproducibility of time-domain and three different frequency-domain techniques for the analysis of the signal-averaged electrocardiogram. J Electrocardiol 33 (2000) 99-105
81. Gottfridsson C., Karlsson T., and Edvardsson N. The short-term and long-term reproducibility of spectral turbulence and late potential variables of the signal-averaged ECG in a population sample of healthy subjects and the impact of gender, age, and noise. J Electrocardiol 33 (2000) 107-117
82. Bloomfield D.M., Snyder J.E., and Steinberg J.S. A critical appraisal of quantitative spectro-temporal analysis of the signal-averaged ECG: predicting arrhythmic events after myocardial infarction. Pacing Clin Electrophysiol 19 (1996) 768-777
83. Kavesh N.G., Cain M.E., Ambos H.D., et al. Enhanced detection of distinguishing features in signal-averaged electrocardiograms from patients with ventricular tachycardia by combined spatial and spectral analyses of entire cardiac cycle. Circulation 90 (1994) 254-263
84. Vázquez R., Caref E.B., Torres F., et al. Short-term reproducibility of time domain, spectral temporal mapping, and spectral turbulence analysis of the signal-averaged electrocardiogram in normal subjects and patients with acute myocardial infarction. Am Heart J 130 (1995) 1011-1019
85. Englund A., Andersson M., and Bergfeldt L. Spectral turbulence analysis of the signal-averaged electrocardiogram for predicting inducible sustained monomorphic ventricular tachycardia in patients with and without bundle branch block. Eur Heart J 16 (1995) 1936-1942
86. Steinbigler P., Haberl R., Brüggemann T., et al. Postinfarction risk assessment for sudden cardiac death using late potential analysis of the digital Holter electrocardiogram. J Cardiovasc Electrophysiol 13 (2002) 1227-1232
87. Ikeda T., Sakata T., Takami M., et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 35 (2000) 722-730
88. Touboul P., Andre-Fouët X., Leizorovicz A., et al., The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI). Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. Eur Heart J 18 (1997) 99-107
89. Kawalsky D.L., Garratt K.N., Hammill S.C., et al. Effect of infarct-related artery patency and late potentials on late mortality after acute myocardial infarction. Mayo Clin Proc 72 (1997) 414-421
90. Hartikainen J.E., Malik M., Staunton A., et al. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 28 (1996) 296-304
91. Steinberg J.S., Hochman J.S., Morgan C.D., et al. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation 90 (1994) 746-752
92. Evrengul H., Dursunoglu D., Kayikcioglu M., et al. Effects of a beta-blocker on ventricular late potentials in patients with acute anterior myocardial infarction receiving successful thrombolytic therapy. Jpn Heart J 45 (2004) 11-21
93. Karam C., Golmard J., and Steg P.G. Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarction. J Am Coll Cardiol 27 (1996) 1343-1348
94. Denes P., el-Sherif N., Katz R., et al., Cardiac Arrhythmia Suppression Trial (CAST) SAECG Substudy Investigators. Prognostic significance of signal-averaged electrocardiogram after thrombolytic therapy and/or angioplasty during acute myocardial infarction (CAST substudy). Am J Cardiol 74 (1994) 216-220
95. Hofmann T., Burmeister A., and Meinertz T. Prognostic significance of the signal averaged electrocardiogram in patients with chronic stable coronary artery disease: analysis in the time domain and by spectral temporal mapping. Z Kardiol 93 (2004) 32-42
96. Gomes J.A., Cain M.E., Buxton A.E., et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001) 436-441
97. Gold M.R., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
98. Bigger Jr. J.T., Whang W., Rottman J.N., et al. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 99 (1999) 1416-1421
99. Scharf C., Redecker H., Duru F., et al. Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG. Ann Thorac Surg 72 (2001) 1546-1551
100. Turitto G., Ahuja R.K., Bekheit S., et al. Incidence and prediction of induced ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 73 (1994) 770-773
101. Turitto G., Ahuja R.K., Caref E.B., et al. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 24 (1994) 1523-1528
102. Kondo N., Ikeda T., Kawase A., et al. Clinical usefulness of the combination of T-wave alternans and late potentials for identifying high-risk patients with moderately or severely impaired left ventricular function. Jpn Circ J 65 (2001) 649-653
103. Fauchier L., Babuty D., Cosnay P., et al. Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. Am J Cardiol 85 (2000) 618-623
104. Goedel-Meinen L., Hofmann M., Ryba S., et al. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy. Am J Cardiol 87 (2001) 809-812
105. Hohnloser S.H., Klingenheben T., Bloomfield D., et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
106. Grimm W., Glaveris C., Hoffmann J., et al. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography. Am Heart J 140 (2000) 43-51
107. Brembilla-Perrot B., Terrier de la Chaise A., Jacquemin L., et al. The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. Am J Cardiol 79 (1997) 154-159
108. Galinier M., Albenque J.P., Afchar N., et al. Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J 17 (1996) 264-271
109. Silverman M.E., Pressel M.D., Brackett J.C., et al. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 75 (1995) 460-464
110. Yi G., Keeling P.J., Goldman J.H., et al. Comparison of time domain and spectral turbulence analysis of the signal-averaged electrocardiogram for the prediction of prognosis in idiopathic dilated cardiomyopathy. Clin Cardiol 19 (1996) 800-808
111. Yi G., Keeling P.J., Goldman J.H., et al. Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 75 (1995) 494-497
112. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93 (1996) 1043-1065
113. Fox K., Borer J.S., Camm A.J., et al., Heart Rate Working Group. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50 (2007) 823-830
114. Lahiri M., Kannankeril P., and Goldberger J. Assessment of autonomic function in cardiovascular disease: physiologic basis and prognostic implications. J Am Coll Cardiol 51 (2008) 1725-1733
115. Sandercock G.R., Bromley P.D., and Brodie D.A. The reliability of short-term measurements of heart rate variability. Int J Cardiol 103 (2005) 238-247
116. Goldberger J.J., Challapalli S., Tung R., et al. Relationship of heart rate variability to parasympathetic effect. Circulation 103 (2001) 1977-1983
117. Dekker J.M., Crow R.S., Folsom A.R., et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 102 (2000) 1239-1244
118. Kuch B., Parvanov T., Hense H.W., et al. Short-period heart rate variability in the general population as compared to patients with acute myocardial infarction from the same source population. Ann Noninvasive Electrocardiol 9 (2004) 113-120
119. La Rovere M.T., Pinna G.D., Maestri R., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107 (2003) 565-570
120. Crawford M.H., Bernstein S.J., Deedwania P.C., et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 34 (1999) 912-948
121. Kotler M.N., Tabatznik B., Mower M.M., et al. Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period. Circulation 47 (1973) 959-966
122. Holmes J., Kubo S.H., Cody R.J., et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 55 (1985) 146-151
123. Denes P., Gillis A.M., Pawitan Y., et al., CAST Investigators. Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 68 (1991) 887-896
124. Tavazzi L., and Volpi A. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) trials. Circulation 95 (1997) 1341-1345
125. Hohnloser S.H., Franck P., Klingenheben T., et al. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation 90 (1994) 1747-1756
126. Cairns J.A., Connolly S.J., Roberts R., et al., Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349 (1997) 675-682
127. Maggioni A.P., Zuanetti G., Franzosi M.G., et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87 (1993) 312-322
128. Julian D.G., Camm A.J., Frangin G., et al., European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349 (1997) 667-674
129. Kron J., Hart M., Schual-Berke S., et al. Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death. Chest 93 (1988) 85-90
130. Huang S.K., Messer J.V., and Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 51 (1983) 507-512
131. Doval H.C., Nul D.R., Grancelli H.O., et al., Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344 (1994) 493-498
132. Doval H.C., Nul D.R., Grancelli H.O., et al., GESICA-GEMA Investigators. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation 94 (1996) 3198-3203
133. Ikegawa T., Chino M., Hasegawa H., et al. Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with dilative cardiomyopathy: a prospective study. Clin Cardiol 10 (1987) 78-82
134. Pelliccia F., Gallo P., Cianfrocca C., et al. Relation of complex ventricular arrhythmias to presenting features and prognosis in dilated cardiomyopathy. Int J Cardiol 29 (1990) 47-54
135. Unverferth D.V., Magorien R.D., Moeschberger M.L., et al. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54 (1984) 147-152
136. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. The preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321 (1989) 406-412
137. Buxton A.E., Lee K.L., Fisher J.D., et al., Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
138. Myers G.A., Martin G.J., Magid N.M., et al. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng 33 (1986) 1149-1156
139. Roach D., Wilson W., Ritchie D., et al. Dissection of long-range heart rate variability: controlled induction of prognostic measures by activity in the laboratory. J Am Coll Cardiol 43 (2004) 2271-2277
140. Tsuji H., Venditti Jr. F.J., Manders E.S., et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham heart study. Circulation 90 (1994) 878-883
141. Kleiger R.E., Miller J.P., Bigger Jr. J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
142. Forslund L., Björkander I., Ericson M., et al. Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris. Heart 87 (2002) 415-422
143. Gerritsen J., Dekker J.M., TenVoorde B.J., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24 (2001) 1793-1798
144. Huikuri H.V., Mäkikallio T.H., Airaksinen K.E., et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 97 (1998) 2031-2036
145. Huikuri H.V., Mäkikallio T.H., Peng C.K., et al. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 101 (2000) 47-53
146. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., et al., ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
147. Camm A.J., Pratt C.M., Schwartz P.J., et al., AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 109 (2004) 990-996
148. Watanabe M.A., Marine J.E., Sheldon R., et al. Effects of ventricular premature stimulus coupling interval on blood pressure and heart rate turbulence. Circulation 106 (2002) 325-330
149. Kawasaki T., Azuma A., Asada S., et al. Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J 67 (2003) 601-604
150. Schmidt G., Malik M., Barthel P., et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353 (1999) 1390-1396
151. Ghuran A., Reid F., La Rovere M.T., et al., ATRAMI Investigators. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol 89 (2002) 184-190
152. Bonnemeier H., Wiegand U.K., Friedlbinder J., et al. Reflex cardiac activity in ischemia and reperfusion: heart rate turbulence in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction. Circulation 108 (2003) 958-964
153. Davies L.C., Francis D.P., Ponikowski P., et al. Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol 87 (2001) 737-742
154. Koyama J., Watanabe J., Yamada A., et al. Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure. Circ J 66 (2002) 902-907
155. Grimm W., Schmidt G., Maisch B., et al. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 14 (2003) 819-824
156. Galvin J.M., and Ruskin J.N. Ventricular tachycardia in patients with dilated cardiomyopathy. In: Zipes D.P., and Jalife J. (Eds). Cardiac Electrophysiology: From Cell to Bedside. 4th ed. (2004), Saunders, Philadelphia, Pa 575-587
157. Pitt B., Zannad F., Remme W.J., et al., Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
158. Whang W., Mittleman M.A., Rich D.Q., et al., TOVA Investigators. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation 109 (2004) 1386-1391
159. Goldman L., Hashimoto B., Cook E.F., et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64 (1981) 1227-1234
160. Meyer K., Westbrook S., Schwaibold M., et al. Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure. Am Heart J 134 (1997) 20-26
161. Mahon N.G., Blackstone E.H., Francis G.S., et al. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40 (2002) 1106-1113
162. Myers J., Gullestad L., Vagelos R., et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 129 (1998) 286-293
163. Imai K., Sato H., Hori M., et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol 24 (1994) 1529-1535
164. Cole C.R., Blackstone E.H., Pashkow F.J., et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341 (1999) 1351-1357
165. Shetler K., Marcus R., Froelicher V.F., et al. Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol 38 (2001) 1980-1987
166. Nishime E.O., Cole C.R., Blackstone E.H., et al. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 284 (2000) 1392-1398
167. Watanabe J., Thamilarasan M., Blackstone E.H., et al. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality. The case of stress echocardiology. Circulation 104 (2001) 1911-1916
168. Jouven X., Empana J.P., Schwartz P.J., et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352 (2005) 1951-1958
169. Vivekananthan D.P., Blackstone E.H., Pothier C.E., et al. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol 42 (2003) 831-838
170. Cheng Y.J., Lauer M.S., Earnest C.P., et al. Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. Diabetes Care 26 (2003) 2052-2057
171. Gibbons R.J. Abnormal heart-rate recovery after exercise. Lancet 359 (2002) 1536-1537
172. Yawn B.P., Ammar K.A., Thomas R., et al. Test-retest reproducibility of heart rate recovery after treadmill exercise. Ann Fam Med 1 (2003) 236-241
173. Frolkis J.P., Pothier C.E., Blackstone E.H., et al. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 348 (2003) 781-790
174. O'Neill J.O., Young J.B., Pothier C.E., et al. Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure. J Am Coll Cardiol 44 (2004) 820-826
175. Rosenbaum D.S., Jackson L.E., Smith J.M., et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
176. Walker M.L., and Rosenbaum D.S. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc Res 57 (2003) 599-614
177. Pastore J.M., Girouard S.D., Laurita K.R., et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 99 (1999) 1385-1394
178. Bloomfield D.M., Ritvo B.S., Parides M.K., et al. The immediate reproducibility of T wave alternans during bicycle exercise. Pacing Clin Electrophysiol 25 (2002) 1185-1191
179. Turitto G., Mirandi A.P., Pedalino R.P., et al. Short-term reproducibility of T wave alternans measurement. J Cardiovasc Electrophysiol 13 (2002) 641-644
180. Klingenheben T., Zabel M., D'Agostino R.B., et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
181. Rashba E.J., Osman A.F., MacMurdy K., et al. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 15 (2004) 170-176
182. Tanno K., Ryu S., Watanabe N., et al. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial pacing. Circulation 109 (2004) 1854-1858
183. Rashba E.J., Osman A.F., MacMurdy K., et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 13 (2002) 845-850
184. Lauer M.S., and Topol E.J. Clinical trials: multiple treatments, multiple end points, and multiple lessons. JAMA 289 (2003) 2575-2577
185. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
186. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
187. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
188. Gehi A.K., Stein R.H., Metz L.D., et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
189. Eckberg D.L., and Sleight P. Human Baroreflexes in Health and Disease (1992), Clarendon Press, Oxford, UK
190. Schwartz P.J., La Rovere M.T., and Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85 (1992) I77-I91
191. La Rovere M.T., Specchia G., Mortara A., et al. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 78 (1988) 816-824
192. Farrell T.G., Paul V., Cripps T.R., et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 83 (1991) 945-952
193. Farrell T.G., Odemuyiwa O., Bashir Y., et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 67 (1992) 129-137
194. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
195. Nazarian S., Bluemke D.A., Lardo A.C., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 (2005) 2821-2825
196. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
197. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
198. Spirito P., Bellone P., Harris K.M., et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
199. Elliott P.M., Gimeno Blanes J.R., Mahon N.G., et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
200. Elliott P.M., Poloniecki J., Dickie S., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
201. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
202. Wilber D.J., Zareba W., Hall W.J., et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 109 (2004) 1082-1084
203. Pitt B., White H., Nicolau J., et al., EPHESUS Investigators. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 46 (2005) 425-431
204. Huikuri H.V., Mahaux V., and Bloch-Thomsen P.E. Cardiac arrhythmias and risk stratification after myocardial infarction: results of the CARISMA pilot study. Pacing Clin Electrophysiol 26 (2003) 416-419
205. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003) 1664-1672
206. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108 (2003) 1772-1778